FUNCTIONAL AND HISTOPATHOLOGIC EFFECTS OF RAPAMYCIN ON MOUSE KIDNEY

被引:10
作者
DIJOSEPH, JF [1 ]
SEHGAL, SN [1 ]
机构
[1] WYETH AYERST RES,CN8000,PRINCETON,NJ 08543
关键词
D O I
10.3109/08923979309066932
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effect of rapamycin (RAPA) on kidney function and histopathology was assessed in two strains of mice. Male C3H/HeJ mice were treated with RAPA for 4 days at doses of 25, 50, 75, and 100 mg/kg, ip and male C3H/HeJ or female Balb/cJ mice were both treated for 7 days at doses of 75, 150 and 200 mg/kg. Cyclosporine (CsA) was also administered to female Balb/cJ mice at doses of 50,100,150 and 200 mg/kg, ip. RAPA-treated mice had elevated BUN levels but the effect was not dose-dependent and was not present in the high dose, 7-day study conducted in the C3H/HeJ mice. Body weights were significantly depressed in both of the 7 day studies but not in the 4 day study. Histopathologic examination of the kidneys revealed the presence of intracytoplasmic vacuolization in the proximal tubules in both of the 7 day studies at the higher dose only. There were no drug-related deaths. In the CsA-treated mice, multiple deaths were recorded in both the 150 mg/kg and 200 mg/kg dose groups, probably related to neurotoxicity, and BUN levels were elevated in the 100 mg/kg dose group. In conclusion, RAPA's effects on kidney function were minimal at doses 50 times higher than its therapeutic dose established in the mouse. RAPA exhibited a better therapeutic index than CsA in the mouse.
引用
收藏
页码:45 / 56
页数:12
相关论文
共 13 条
[1]   TISSUE DISTRIBUTION AND TOXICITY OF CYCLOSPORIN A IN THE MOUSE [J].
BOLAND, J ;
ATKINSON, K ;
BRITTON, K ;
DARVENIZA, P ;
JOHNSON, S ;
BIGGS, J .
PATHOLOGY, 1984, 16 (02) :117-123
[2]  
DIJOSEPH J F, 1991, Journal of the American Society of Nephrology, V2, P781
[3]   THE EFFECT OF RAPAMYCIN ON KIDNEY-FUNCTION IN THE SPRAGUE-DAWLEY RAT [J].
DIJOSEPH, JF ;
SHARMA, RN ;
CHANG, JY .
TRANSPLANTATION, 1992, 53 (03) :507-513
[4]  
DIJOSEPH JF, 1992, IN PRESS TRANSPL P
[5]  
ENG CP, 1991, TRANSPLANT P, V23, P868
[6]  
KAHAN BD, 1989, NEW ENGL J MED, V321, P1725
[7]  
MASRI MA, 1988, TRANSPLANT INT, V1, P13
[8]  
MORRIS RE, 1990, TRANSPLANT P, V22, P1638
[9]  
MORRIS RE, 1991, IMMUNOL TODAY, V12, P138
[10]  
Sehgal SN, 1990, TRANSPLANT IMMUNOL L, V7, P12